Presentation

2024-0222 GVIRF Webinar: New Tuberculosis Vaccines for Adults and Adolescents: Progress, Prospects, and Perspectives - PRESENTATIONS

It’s an exciting time for new TB vaccine development! Several vaccine candidates are in late stage product development, with Phase III trial data available as early as 2024 and potential licensure and use in some countries in the near future. However, none of the candidates are expected to be a ‘silver bullet’ and there are differences in terms of trial design, primary endpoint, target population, and product attributes. Without a known correlate of protection, the effect of HIV status, infection status, age and geography on vaccine efficacy must be determined for each vaccine. We also need to ensure that the early pipeline remains robust in terms of new antigenic targets and platforms, and that new tools are developed to effectively evaluate their potential efficacy.

This webinar brought together experts to discuss the status of TB vaccine development across the value chain, from articulation of the public health and economic need for new TB vaccines, through the status and strategies for product development, to the considerations for approval, policy recommendation and use. 

Languages

  • English

Publication year

2024

Type

Presentation

Categories

  • Programme management

Diseases

  • TB

Topic references

GVIRF-webinar

TitleAuthorYearTypeLanguage
2021-10-14 mRNA Vaccine Technologies for Global Health - AGENDAGVIRF Secretariat2021PresentationEnglish
2021-10-14 mRNA Vaccine Technologies for Global Health - PRESENTATIONSGVIRF Secretariat2021PresentationEnglish
2021-10-14 mRNA Vaccine Technologies for Global Health - VIDEOGVIRF Secretariat2022WebinarEnglish
2022-03-03 Malaria Vaccine R&D and Immunization Lessons Learned and Considerations for Global Health Impact - VIDEOGVIRF Secretariat2022WebinarEnglish
2022-03-03 Malaria Vaccine R&D and Immunization: Lessons Learned and Considerations for Global Health Impact - AGENDAGVIRF Secretariat2022PresentationEnglish
2022-06-23 AMR: Las vacunas como herramientas para prevenir la RAM - VIDEOGVIRF Secretariat2022WebinarSpanish
2022-06-23 AMR: Les vaccins comme outils de prévention de la RAM - VIDEOGVIRF Secretariat2022WebinarFrench
2022-06-23 AMR: Vaccines as Tools to Prevent Antimicrobial Resistance - VIDEOGVIRF Secretariat2022WebinarEnglish
2022-06-23 AMR: Vaccines as Tools to Prevent Antimicrobial Resistance: Advances, challenges, and future development - AGENDAGVIRF Secretariat2022PresentationEnglish
2022-06-23 Vaccines as Tools to Prevent Antimicrobial Resistance: Advances, challenges, and future development - WEBINAR ANNOUNCEMENTGVIRF Secretariat2022PresentationEnglish
2022-10-12 Correlates of Protection - VIDEOGVIRF Secretariat2022WebinarEnglish
2023-09-13 Webinar: Vaccine Adjuvants for Global Health - Final AGENDAGVIRF Secretariat2023WebinarEnglish
2023-09-13 Webinar: Vaccine Adjuvants for Global Health - Session I Global Demand for Vaccine AdjuvantsGVIRF Secretariat2023PresentationEnglish
2023-09-13 Webinar: Vaccine Adjuvants for Global Health - Session II Selection of Adjuvant and Formulation for Vaccine R&D: rational or empirical?GVIRF Secretariat2023PresentationEnglish
2023-09-13 Webinar: Vaccine Adjuvants for Global Health - Session III Access to AdjuvantsGVIRF Secretariat2023PresentationEnglish
2023-09-13 Webinar: Vaccine Adjuvants for Global Health - VIDEOGVIRF Secretariat2023WebinarEnglish
2024-0222 GVIRF Webinar: New TB Vaccines for Adults & Adolescents: Progress, Prospects and Perspectives; February 22, 2024 - FINAL AGENDAGVIRF Secretariat2024WebinarEnglish
2024-0222 GVIRF Webinar: New TB Vaccines for Adults and Adolescents - VIDEOGVIRF Secretariat2024WebinarEnglish
2024-0222 GVIRF Webinar: New TB Vaccines for Adults and Adolescents, Progress, Prospects, and Perspectives, February 22, 2024 - ANNOUNCEMENTGVIRF Secretariat2024WebinarEnglish
2024-0222 GVIRF Webinar: New Tuberculosis Vaccines for Adults and Adolescents: Progress, Prospects, and Perspectives - PRESENTATIONSGVIRF Secretariat, Richard White, Nebiat Gebreselassie, Mark Hatherill, Ann Ginsberg, Nicole Frahm, Munyaradzi Musvosvi, David Lewinsohn, Shelly Malhotra, Rupali Limaye, Birgitte Giersing2024PresentationEnglish
2024-0222 GVIRF Webinar: Nouveaux vaccins antituberculeux pour adultes et adolescents - VIDEOGVIRF Secretariat2024WebinarFrench
2024-0222 GVIRF Webinar: Nuevas vacunas contra la tuberculosis para adultos y adolescentes - VIDEOGVIRF Secretariat2024WebinarSpanish

Added by: Moderator

Added on: 2024-03-05 14:03:01

Hits: 560

Uploaded file

consolidated deck TB GVIRF .pdf

Click to Download